Format
Sort by

Send to

Choose Destination

Search results

Items: 19

1.

BI 1002494, a Novel Potent and Selective Oral Spleen Tyrosine Kinase Inhibitor, Displays Differential Potency in Human Basophils and B Cells.

Lamb DJ, Wollin SL, Schnapp A, Bischoff D, Erb KJ, Bouyssou T, Guilliard B, Strasser C, Wex E, Blum S, Thaler E, Nickel H, Radmacher O, Haas H, Swantek JL, Souza D, Canfield M, White D, Panzenbeck M, Kashem MA, Sanville-Ross M, Kono T, Sewald K, Braun A, Obernolte H, Danov O, Schaenzle G, Rast G, Maier GM, Hoffmann M.

J Pharmacol Exp Ther. 2016 Jun;357(3):554-61. doi: 10.1124/jpet.116.233155. Epub 2016 Apr 5.

PMID:
27048659
2.

A High-Throughput Genetic Complementation Assay in Yeast Cells Identified Selective Inhibitors of Sphingosine Kinase 1 Not Found Using a Cell-Free Enzyme Assay.

Kashem MA, Kennedy CA, Fogarty KE, Dimock JR, Zhang Y, Sanville-Ross ML, Skow DJ, Brunette SR, Swantek JL, Hummel HS, Swindle J, Nelson RM.

Assay Drug Dev Technol. 2016 Jan-Feb;14(1):39-49. doi: 10.1089/adt.2015.671. Epub 2015 Oct 1.

PMID:
26426296
3.

Comprehensive profiling analysis of actively resorbing osteoclasts identifies critical signaling pathways regulated by bone substrate.

Purdue PE, Crotti TN, Shen Z, Swantek J, Li J, Hill J, Hanidu A, Dimock J, Nabozny G, Goldring SR, McHugh KP.

Sci Rep. 2014 Dec 23;4:7595. doi: 10.1038/srep07595.

4.

Creating and analyzing pathway and protein interaction compendia for modelling signal transduction networks.

Kirouac DC, Saez-Rodriguez J, Swantek J, Burke JM, Lauffenburger DA, Sorger PK.

BMC Syst Biol. 2012 May 1;6:29. doi: 10.1186/1752-0509-6-29.

5.

Hemostasis in oral surgery.

Kamoh A, Swantek J.

Dent Clin North Am. 2012 Jan;56(1):17-23, vii. doi: 10.1016/j.cden.2011.06.004. Epub 2011 Oct 7.

PMID:
22117940
6.

A technique for long term decompression of large mandibular cysts.

Swantek JJ, Reyes MI, Grannum RI, Ogle OE.

J Oral Maxillofac Surg. 2012 Apr;70(4):856-9. doi: 10.1016/j.joms.2011.03.029. Epub 2011 Jul 30.

PMID:
21803472
7.

Hemostatic agents.

Ogle OE, Swantek J, Kamoh A.

Dent Clin North Am. 2011 Jul;55(3):433-9, vii. doi: 10.1016/j.cden.2011.02.005.

PMID:
21726681
8.

Cloning and expression of human mitogen-activated protein kinase kinase 7gamma1.

Michael L, Swantek J, Robinson MJ.

Biochem Biophys Res Commun. 2006 Mar 17;341(3):679-83. Epub 2006 Jan 18.

PMID:
16442502
9.

IL-1 receptor-associated kinase modulates host responsiveness to endotoxin.

Swantek JL, Tsen MF, Cobb MH, Thomas JA.

J Immunol. 2000 Apr 15;164(8):4301-6.

10.

Stimulation of NFkappa B activity by multiple signaling pathways requires PAK1.

Frost JA, Swantek JL, Stippec S, Yin MJ, Gaynor R, Cobb MH.

J Biol Chem. 2000 Jun 30;275(26):19693-9.

11.

Normal hematopoiesis and inflammatory responses despite discrete signaling defects in Galpha15 knockout mice.

Davignon I, Catalina MD, Smith D, Montgomery J, Swantek J, Croy J, Siegelman M, Wilkie TM.

Mol Cell Biol. 2000 Feb;20(3):797-804.

12.

New insights into the control of MAP kinase pathways.

English J, Pearson G, Wilsbacher J, Swantek J, Karandikar M, Xu S, Cobb MH.

Exp Cell Res. 1999 Nov 25;253(1):255-70. Review. No abstract available.

PMID:
10579927
14.
15.
17.

Dissociation of mitogenesis and transforming activity by C-terminal truncation of the insulin-like growth factor-I receptor.

Surmacz E, Sell C, Swantek J, Kato H, Roberts CT Jr, LeRoith D, Baserga R.

Exp Cell Res. 1995 May;218(1):370-80.

PMID:
7737373
18.

An E2F binding sequence negatively regulates the response of the insulin-like growth factor 1 (IGF-I) promoter to simian virus 40T antigen and to serum.

Porcu P, GraƱa X, Li S, Swantek J, De Luca A, Giordano A, Baserga R.

Oncogene. 1994 Aug;9(8):2125-34.

PMID:
8035997
19.

IGF-1 receptor levels and the proliferation of young and senescent human fibroblasts.

Sell C, Ptasznik A, Chang CD, Swantek J, Cristofalo VJ, Baserga R.

Biochem Biophys Res Commun. 1993 Jul 15;194(1):259-65.

PMID:
7687431
Items per page

Supplemental Content

Loading ...
Write to the Help Desk